Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

NCT03976843 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

175

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 18F-DCFPyL

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]